- Home
- NVCT vs GF Comparison
NVCT vs GF Comparison
Compare NVCT & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- GF
- Stock Information
- Founded
- NVCT 2020
- GF 1990
- Country
- NVCT United States
- GF Germany
- Employees
- NVCT N/A
- GF N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- GF Investment Managers
- Sector
- NVCT Health Care
- GF Finance
- Exchange
- NVCT Nasdaq
- GF Nasdaq
- Market Cap
- NVCT 119.4M
- GF 138.1M
- IPO Year
- NVCT 2022
- GF N/A
- Fundamental
- Price
- NVCT $4.90
- GF $8.00
- Analyst Decision
- NVCT Strong Buy
- GF
- Analyst Count
- NVCT 1
- GF 0
- Target Price
- NVCT $21.00
- GF N/A
- AVG Volume (30 Days)
- NVCT 303.6K
- GF 28.1K
- Earning Date
- NVCT 11-05-2024
- GF 01-01-0001
- Dividend Yield
- NVCT N/A
- GF 0.82%
- EPS Growth
- NVCT N/A
- GF N/A
- EPS
- NVCT N/A
- GF N/A
- Revenue
- NVCT N/A
- GF N/A
- Revenue This Year
- NVCT N/A
- GF N/A
- Revenue Next Year
- NVCT N/A
- GF N/A
- P/E Ratio
- NVCT N/A
- GF N/A
- Revenue Growth
- NVCT N/A
- GF N/A
- 52 Week Low
- NVCT $4.69
- GF $7.38
- 52 Week High
- NVCT $12.10
- GF $9.41
- Technical
- Relative Strength Index (RSI)
- NVCT 35.71
- GF 29.93
- Support Level
- NVCT $4.75
- GF $8.20
- Resistance Level
- NVCT $5.49
- GF $8.35
- Average True Range (ATR)
- NVCT 1.14
- GF 0.11
- MACD
- NVCT -0.52
- GF -0.03
- Stochastic Oscillator
- NVCT 3.02
- GF 10.00
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a United States-based non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.